secwatch.observer — SEC 8-K summary
======================================

Issuer:     Summit Therapeutics Inc. (SMMT)
CIK:        0001599298
Form:       8-K
Filed at:   2024-02-08T23:59:59+00:00
Accession:  0001599298-24-000023
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Summit Therapeutics to present at Oppenheimer Healthcare Conference on Feb 14
-----------------------------------------------------------------------------

- Presentation at Oppenheimer's 34th Annual Healthcare Life Sciences Conference on February 14, 2024 at 2:40PM ET.
- Dr. Maky Zanganeh (CEO/President) and Robert W. Duggan (Chairman/CEO) will present on ivonescimab development.
- Webcast available live and archived on Summit's website at www.smmttx.com.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1599298/000159929824000023/0001599298-24-000023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1599298/000159929824000023/smmt-20240207.htm
  HTML page:      https://secwatch.observer/filing/0001599298-24-000023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer